These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35299995)

  • 21. Tests for inter-subject and total variabilities under crossover designs.
    Lee Y; Shao J; Chow SC; Wang H
    J Biopharm Stat; 2002 Nov; 12(4):503-34. PubMed ID: 12477072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crossover design in pharmacy research.
    Cody RL; Slack MK
    Ann Pharmacother; 1992 Mar; 26(3):327-33. PubMed ID: 1532519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nurse staffing level and nosocomial infections: empirical evaluation of the case-crossover and case-time-control designs.
    Hugonnet S; Villaveces A; Pittet D
    Am J Epidemiol; 2007 Jun; 165(11):1321-7. PubMed ID: 17400571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-Armed Angle-Based Direct Learning for Estimating Optimal Individualized Treatment Rules With Various Outcomes.
    Qi Z; Liu D; Fu H; Liu Y
    J Am Stat Assoc; 2020; 115(530):678-691. PubMed ID: 34219848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Testing treatment-by-period interaction in four-period crossover trials.
    Li B; Zhou Z; Zhang L; Yang Y
    Pharm Stat; 2020 Mar; 19(2):145-163. PubMed ID: 31828937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absorbent products for urinary/faecal incontinence: a comparative evaluation of key product designs.
    Fader M; Cottenden A; Getliffe K; Gage H; Clarke-O'Neill S; Jamieson K; Green N; Williams P; Brooks R; Malone-Lee J
    Health Technol Assess; 2008 Jul; 12(29):iii-iv, ix-185. PubMed ID: 18547500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A clinical trial design with covariate-adjusted response-adaptive randomization using superiority confidence of treatments.
    Qiao W; Ning J; Huang X
    Stat Biopharm Res; 2019; 11(4):336-347. PubMed ID: 34113421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequential rank agreement methods for comparison of ranked lists.
    Ekstrøm CT; Gerds TA; Jensen AK
    Biostatistics; 2019 Oct; 20(4):582-598. PubMed ID: 29868883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bayesian designs of phase II oncology trials to select maximum effective dose assuming monotonic dose-response relationship.
    Guo B; Li Y
    BMC Med Res Methodol; 2014 Jul; 14():95. PubMed ID: 25074481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimation of the treatment effect under an incomplete block crossover design in binary data - A conditional likelihood approach.
    Lui KJ
    Stat Methods Med Res; 2017 Oct; 26(5):2197-2209. PubMed ID: 26184831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Part 1. Statistical Learning Methods for the Effects of Multiple Air Pollution Constituents.
    Coull BA; Bobb JF; Wellenius GA; Kioumourtzoglou MA; Mittleman MA; Koutrakis P; Godleski JJ
    Res Rep Health Eff Inst; 2015 Jun; (183 Pt 1-2):5-50. PubMed ID: 26333238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two-wave two-phase outcome-dependent sampling designs, with applications to longitudinal binary data.
    Tao R; Mercaldo ND; Haneuse S; Maronge JM; Rathouz PJ; Heagerty PJ; Schildcrout JS
    Stat Med; 2021 Apr; 40(8):1863-1876. PubMed ID: 33442883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dependence calibration in conditional copulas: a nonparametric approach.
    Acar EF; Craiu RV; Yao F
    Biometrics; 2011 Jun; 67(2):445-53. PubMed ID: 20731648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Aggregated N-of-1 Trials with Parallel and Crossover Randomized Controlled Trials Using Simulation Studies.
    Blackston JW; Chapple AG; McGree JM; McDonald S; Nikles J
    Healthcare (Basel); 2019 Nov; 7(4):. PubMed ID: 31698799
    [No Abstract]   [Full Text] [Related]  

  • 35. Conditional-cumulant-of-exposure method in logistic missing covariate regression.
    Wang CY; Huang WT
    Biometrics; 2000 Mar; 56(1):98-105. PubMed ID: 10783782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analyzing multivariate data in crossover designs using permutation tests.
    Johnson WD; Mercante DE
    J Biopharm Stat; 1996 Jul; 6(3):327-42. PubMed ID: 8854236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bayesian analysis of time-series data under case-crossover designs: posterior equivalence and inference.
    Li S; Mukherjee B; Batterman S; Ghosh M
    Biometrics; 2013 Dec; 69(4):925-36. PubMed ID: 24289144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stability of ranked gene lists in large microarray analysis studies.
    Stiglic G; Kokol P
    J Biomed Biotechnol; 2010; 2010():616358. PubMed ID: 20625502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Case-crossover design: Basic essentials and applications].
    Carracedo-Martínez E; Tobías A; Saez M; Taracido M; Figueiras A
    Gac Sanit; 2009; 23(2):161-5. PubMed ID: 19303669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of phase I dose-finding designs in clinical trials with monotonicity assumption violation.
    Abbas R; Rossoni C; Jaki T; Paoletti X; Mozgunov P
    Clin Trials; 2020 Oct; 17(5):522-534. PubMed ID: 32631095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.